Showing results (821-830 of 1,453) with videos related to
Sort By:
Pageof 146
Glycobiology|January 23, 2020
Application of a gut-immune co-culture system for the study of N-glycan-dependent host-pathogen interactions of Campylobacter jejuniCristina Y Zamora, Elizabeth M Ward, Jemila C Kester, et al.Nanotechnology|December 14, 2011
Interaction of hydrogen with ZnO nanopowders--evidence of hydroxyl group formationKester W J Wong, Matthew R Field, Jian Zhen Ou, et al.Respiratory Care|November 1, 1993
Physician-ordered respiratory care vs physician-ordered use of a respiratory therapy consult service: early experience at The Cleveland Clinic FoundationJ K Stoller, D Haney, J Burkhart, et al.Journal of Medicinal Chemistry|February 16, 1996
Azole endothelin antagonists. 2. Structure-activity studiesT W von Geldern, J A Kester, R Bal, et al.ACS Nano|October 23, 2018
Computational and Experimental Investigation of Janus-like Monolayers on Ultrasmall Noble Metal NanoparticlesSteven N Merz, Zachary J Farrell, Joseph Pearring, et al.North American Journal of Medical Sciences|January 10, 2014
Cardiovascular risk assessment in prediabetes and undiagnosed diabetes mellitus study: international collaboration research overviewEzekiel Uba Nwose, Ross Stuart Richards, Kester Digban, et al.The Journal of Pediatrics|November 20, 2001
Body composition in Prader-Willi syndrome compared with nonsyndromal obesity: Relationship to physical activity and growth hormone functionE G van Mil, K R Westerterp, W J Gerver, et al.European Journal of Clinical Microbiology|June 1, 1986
Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coliF Namavar, J A Kaan, A M Verweij-van Vught, et al.Journal of Medicinal Chemistry|February 16, 1996
Azole endothelin antagonists. 1. A receptor model explains an unusual structure-activity profileT W von Geldern, C Hutchins, J A Kester, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2007
Promiscuity of the AlloHLA-A2 restricted T cell repertoire hampers the generation of minor Histocompatibility antigen-specific cytotoxic T cells across HLA barriersLiesbeth E M Oosten, Els Blokland, Michel G D Kester, et al.Pageof 146